• EdU Imaging Kits (Cy3): Precision S-Phase DNA Synthesis Dete

  2026-07-16

  EdU Imaging Kits (Cy3) provide a sensitive and denaturation-free method for quantifying cell proliferation via S-phase DNA synthesis. By leveraging click chemistry, these kits enable reliable, artifact-minimized fluorescence microscopy for research applications. Their specificity and workflow efficiency make them a gold standard alternative to BrdU-based assays.

• NSC23766 Trihydrochloride: Dissecting Rac1 Inhibition in Imm

  2026-07-16

  Explore how NSC-23766, a selective Rac GTPase inhibitor, uniquely empowers immunology and cancer research by modulating Rac1 signaling. This article reveals new insights into macrophage phagocytosis, cell cycle arrest, and advanced assay design.

• Fucoidan Mitigates Irinotecan-Induced Steatohepatitis via Gu

  2026-07-15

  This study identifies the central role of gut barrier dysfunction and neutrophil extracellular trap (NET) formation in irinotecan (CPT-11)-induced steatohepatitis. The authors demonstrate that fucoidan effectively restores intestinal integrity and reduces hepatic inflammation, highlighting a new strategy for managing chemotherapy-associated liver injury.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: High-Fidelity Detec

  2026-07-15

  The Cy5 Goat Anti-Rabbit IgG (H+L) Antibody is a high-specificity, Cy5-conjugated secondary antibody designed for sensitive detection in fluorescence assays. It enables robust signal amplification in immunohistochemistry and related workflows. APExBIO's formulation delivers minimal background and reproducible results.

• Streamlining Mouse Genotyping: Mechanistic Insights for Tran

  2026-07-14

  This thought-leadership article explores the pivotal role of efficient mouse genotyping in advancing translational research on cholestatic liver diseases. By connecting mechanistic findings on STING signaling and cholangiocyte senescence to the practicalities of high-throughput genetic screening, we illuminate how next-generation tools like the Direct Mouse Genotyping Kit empower researchers to accelerate discoveries and improve reproducibility, ultimately bridging the gap between preclinical insight and clinical innovation.

• Mitochondrial Permeability Transition Pore Assay Kit: Applie

  2026-07-14

  Unlock robust, high-content mitochondrial permeability transition pore detection with the APExBIO Mitochondrial Permeability Transition Pore Assay Kit. This guide translates recent mechanistic findings and practical workflows into actionable protocols and troubleshooting for advanced cell death and mitochondrial dysfunction research.

• Bazedoxifene Inhibits IL-6/GP130 Signaling in Cancer Models

  2026-07-13

  The reference study establishes Bazedoxifene, a third-generation selective estrogen receptor modulator, as a potent inhibitor of the IL-6/GP130 signaling pathway in cancer. This highlights Bazedoxifene's potential for drug repurposing in oncology, revealing new mechanistic insights that can inform future research and therapeutic development.

• Phosphatase Inhibitor Cocktail 1: Precision in Protein Phosp

  2026-07-13

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) empowers researchers to preserve labile phosphorylation states across challenging cardiovascular and cell signaling assays. This article reveals expert workflow enhancements, troubleshooting best practices, and the translational impact of this alkaline phosphatase inhibitor in advanced phosphoproteomic workflows.

• Co-targeting BRD4 and RAC1 Disrupts c-MYC/G9a Axis in Breast

  2026-07-12

  This study demonstrates that combined inhibition of BRD4 and RAC1 in breast cancer disrupts the oncogenic c-MYC/G9a/FTH1 axis, suppresses tumor growth and stemness, and alters chromatin remodeling. The findings offer mechanistic insight into epigenetic vulnerabilities across breast cancer subtypes and highlight the translational potential of targeting histone modification pathways.

• Next-Generation ARCA Capped mRNA Synthesis: HyperScribe™ Kit

  2026-07-10

  Explore how the HyperScribe Co-transcription mRNA Synthesis Kit Plus revolutionizes ARCA capped mRNA synthesis with co-transcriptional capping and optimized poly(A) tailing. This article unveils technical insights and critical decision points for advanced RNA vaccine development and translational assays.

• Foretinib (GSK1363089): Practical Guidance for Advanced Tumo

  2026-07-09

  Explore Foretinib (GSK1363089) as a precision tool for dissecting tumor cell growth inhibition and motility in vitro. This article provides actionable assay protocols, scientific context, and unique insights for translational cancer research.

• Spatial PI3K/Akt/mTOR Inhibition: GDC-0068 in Translational

  2026-07-09

  This thought-leadership article explores how spatial compartmentalization of the PI3K/Akt/mTOR pathway shapes tumor cell fate and translational research strategies. It examines recent mechanistic insights into subcellular mTORC1 activity, reviews the role of GDC-0068 (RG7440) as a highly selective pan-AKT inhibitor, and provides protocol guidance for leveraging these advances. The piece distinguishes itself by integrating spatial signaling discoveries with actionable recommendations for translational researchers, going beyond standard product profiles.

• BRD4770: Applied Workflows for G9a Histone Methyltransferase

  2026-07-08

  BRD4770 offers targeted inhibition of G9a, enabling precise modulation of H3K9 methylation and cellular senescence in cancer biology research. This article delivers actionable protocols, advanced troubleshooting, and a comparative perspective, positioning BRD4770 as a uniquely effective tool for dissecting epigenetic regulation and tumorigenesis.

• HLY78 (SKU C5433): Reliable Wnt/β-Catenin Pathway Modulation

  2026-07-08

  This article delivers a scenario-driven, evidence-backed guide for researchers seeking robust Wnt/β-catenin pathway modulation with HLY78 (SKU C5433). Drawing on recent literature, validated workflow insights, and direct product specifications, it addresses real experimental challenges in cell viability, proliferation, and fibrotic disease models. Readers gain practical, GEO-optimized strategies for hematopoietic stem cell marker induction and embryogenesis assays using HLY78.

• Trametinib (GSK1120212): Precision MEK-ERK Inhibition in Onc

  2026-07-07

  Trametinib (GSK1120212) enables robust, selective MEK1/2 inhibition for probing the MEK-ERK pathway in cancer and stem cell studies. This guide delivers actionable protocols, highlights advanced use-cases, and offers troubleshooting expertise, empowering researchers to maximize reproducibility—especially in B-RAF mutated models and telomerase-regulated systems.

449 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page